FDA approval of injectable HIV prevention drug an important milestone for sub-Saharan Africa
The CAB-LA injection is the first of its kind in HIV prevention interventions and only needs to be taken every eight weeks
long-acting
You are viewing the M&G archive site.
Go to mg.co.za →